Profil
Cees Wortel currently works at Vesalius Biocapital Partners SARL, as Venture Partner from 2016.
Dr. Wortel also formerly worked at Galapagos NV, as Chief Medical Officer.
Dr. Wortel received his doctorate degree in 1993 from the University of Amsterdam.
Aktiva positioner av Cees Wortel
| Företag | Position | Start |
|---|---|---|
Vesalius Biocapital Partners SARL
Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors. | Privat kapitalinvesterare | 2016-01-01 |
Tidigare kända positioner av Cees Wortel
| Företag | Position | Slut |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Teknisk/Vetenskaplig/F&U Direktör | - |
Cees Wortels utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
University of Amsterdam
University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vesalius Biocapital Partners SARL
Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors. | Finance |
















